title: The development of MDA-7/IL-24 as a cancer therapeutic.
abstract: The cytokine melanoma differentiation associated gene 7 (mda-7) was identified by subtractive hybridization as a protein whose expression increased during the induction of terminal differentiation, and that was either not expressed or was present at low levels in tumor cells compared to non-transformed cells. Based on conserved structure, chromosomal location and cytokine-like properties, MDA-7, was classified as a member of the interleukin (IL)-10 gene family and designated as MDA-7/IL-24. Multiple studies have demonstrated that expression of MDA-7/IL-24 in a wide variety of tumor cell types, but not in corresponding equivalent non-transformed cells, causes their growth arrest and rapid cell death. In addition, MDA-7/IL-24 has been noted to radiosensitize tumor cells which in part is due to the generation of reactive oxygen species (ROS) and ceramide that cause endoplasmic reticulum stress and suppress protein translation. Phase I clinical trial data has shown that a recombinant adenovirus expressing MDA-7/IL-24 (Ad.mda-7 (INGN-241)) was safe and had measurable tumoricidal effects in over 40% of patients, strongly arguing that MDA-7/IL-24 could have significant therapeutic value. This review describes what is presently known about the impact of MDA-7/IL-24 on tumor cell biology and its potential therapeutic applications.
authors: Department of Neurosurgery, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA. pdent@vcu.edu
authors: Paul
authors: P
authors: Dent
authors: Adly
authors: A
authors: Yacoub
authors: Hossein A
authors: HA
authors: Hamed
authors: Margaret A
authors: MA
authors: Park
authors: Rupesh
authors: R
authors: Dash
authors: Sujit K
authors: SK
authors: Bhutia
authors: Devanand
authors: D
authors: Sarkar
authors: Xiang-Yang
authors: XY
authors: Wang
authors: Pankaj
authors: P
authors: Gupta
authors: Luni
authors: L
authors: Emdad
authors: Irina V
authors: IV
authors: Lebedeva
authors: Moira
authors: M
authors: Sauane
authors: Zhao-zhong
authors: ZZ
authors: Su
authors: Mohamed
authors: M
authors: Rahmani
authors: William C
authors: WC
authors: Broaddus
authors: Harold F
authors: HF
authors: Young
authors: Maciej S
authors: MS
authors: Lesniak
authors: Steven
authors: S
authors: Grant
authors: David T
authors: DT
authors: Curiel
authors: Paul B
authors: PB
authors: Fisher
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D055808:Drug Discovery / Q000379:methods* / Q000639:trends; D006801:Humans; D007378:Interleukins / Q000096:biosynthesis / Q000235:genetics / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D000099180:Interleukin-24
chemical_list: D000970:Antineoplastic Agents; D007378:Interleukins; D000099180:Interleukin-24